Asundexian versus Apixaban in Patients with Atrial Fibrillation.

Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V, OCEANIC-AF Steering Committee and Investigators

Open source

DOI: 10.1056/nejmoa2407105
Published: 2025 Jan 2
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2407105,
  title = {Asundexian versus Apixaban in Patients with Atrial Fibrillation.},
  author = {Piccini JP and Patel MR and Steffel J and Ferdinand K and Van Gelder IC and Russo AM and Ma CS and Goodman SG and Oldgren J and Hammett C and Lopes RD and Akao M and De Caterina R and Kirchhof P and Gorog DA and Hemels M and Rienstra M and Jones WS and Harrington J and Lip GYH and Ellis SJ and Rockhold FW and Neumann C and Alexander JH and Viethen T and Hung J and Coppolecchia R and Mundl H and Caso V and OCEANIC-AF Steering Committee and Investigators},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2407105},
  url = {https://doi.org/10.1056/nejmoa2407105}
}

RIS

TY  - JOUR
TI  - Asundexian versus Apixaban in Patients with Atrial Fibrillation.
AU  - Piccini JP
AU  - Patel MR
AU  - Steffel J
AU  - Ferdinand K
AU  - Van Gelder IC
AU  - Russo AM
AU  - Ma CS
AU  - Goodman SG
AU  - Oldgren J
AU  - Hammett C
AU  - Lopes RD
AU  - Akao M
AU  - De Caterina R
AU  - Kirchhof P
AU  - Gorog DA
AU  - Hemels M
AU  - Rienstra M
AU  - Jones WS
AU  - Harrington J
AU  - Lip GYH
AU  - Ellis SJ
AU  - Rockhold FW
AU  - Neumann C
AU  - Alexander JH
AU  - Viethen T
AU  - Hung J
AU  - Coppolecchia R
AU  - Mundl H
AU  - Caso V
AU  - OCEANIC-AF Steering Committee and Investigators
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2407105
UR  - https://doi.org/10.1056/nejmoa2407105
ER  -

APA

JP, P., MR, P., J, S., K, F., IC, V. G., AM, R., CS, M., SG, G., J, O., C, H., RD, L., M, A., R, D. C., P, K., DA, G., M, H., M, R., WS, J., J, H., GYH, L., SJ, E., FW, R., C, N., JH, A., T, V., J, H., R, C., H, M., V, C., & Investigators, O. S. C. A. (2025). Asundexian versus Apixaban in Patients with Atrial Fibrillation.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2407105

Source records

pubmed · retrieved 2026-09-27T01:03:42.537Z